# Amalgamated Financial Corp.: financial statements, quarterly

AMAL · Nasdaq · CIK 1823608 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amal.md) · [Financials](/companies/amal/financials.md) · [Filings](/companies/amal/filings.md) · [Insiders](/companies/amal/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amal/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [27.5](/filings/0001823608-23-000127.md) | [28.7 d](/filings/0001823608-24-000076.md) | [28.9](/filings/0001823608-24-000121.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [8.8](/filings/0001823608-24-000183.md) | [12.5 d](/filings/0001823608-26-000048.md) | [11.3](/filings/0001823608-25-000049.md) | [9.0](/filings/0001823608-25-000076.md) | [10.3](/filings/0001823608-25-000113.md) | [8.6 d](/filings/0001823608-26-000048.md) | [9.7](/filings/0001823608-26-000113.md) | [9.5](/filings/0001823608-26-000182.md) | [9.9](/filings/0001823608-25-000113.md) | [6.6 d](/filings/0001823608-26-000048.md) | [8.8](/filings/0001823608-26-000113.md) | [11.9](/filings/0001823608-26-000182.md) |
| Net income | $m | [22.3](/filings/0001823608-24-000183.md) | [22.7 d](/filings/0001823608-26-000048.md) | [27.2](/filings/0001823608-25-000049.md) | [26.8](/filings/0001823608-25-000076.md) | [27.9](/filings/0001823608-25-000113.md) | [24.5 d](/filings/0001823608-26-000048.md) | [25.0](/filings/0001823608-26-000113.md) | [26.0](/filings/0001823608-26-000182.md) | [26.8](/filings/0001823608-25-000113.md) | [26.6 d](/filings/0001823608-26-000048.md) | [25.2](/filings/0001823608-26-000113.md) | [34.8](/filings/0001823608-26-000182.md) |
| Diluted EPS | $ per share | [0.73](/filings/0001823608-24-000183.md) | not reported | [0.89](/filings/0001823608-25-000049.md) | [0.87](/filings/0001823608-25-000076.md) | [0.90](/filings/0001823608-25-000113.md) | not reported | [0.81](/filings/0001823608-26-000113.md) | [0.84](/filings/0001823608-26-000182.md) | [0.88](/filings/0001823608-25-000113.md) | not reported | [0.84](/filings/0001823608-26-000113.md) | [1.15](/filings/0001823608-26-000182.md) |
| Basic EPS | $ per share | [0.73](/filings/0001823608-24-000183.md) | not reported | [0.89](/filings/0001823608-25-000049.md) | [0.88](/filings/0001823608-25-000076.md) | [0.91](/filings/0001823608-25-000113.md) | not reported | [0.82](/filings/0001823608-26-000113.md) | [0.85](/filings/0001823608-26-000182.md) | [0.89](/filings/0001823608-25-000113.md) | not reported | [0.85](/filings/0001823608-26-000113.md) | [1.16](/filings/0001823608-26-000182.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [140](/filings/0001823608-23-000127.md) | [90.6](/filings/0001823608-25-000015.md) | [155](/filings/0001823608-24-000121.md) | [58.0](/filings/0001823608-24-000164.md) | [149](/filings/0001823608-24-000183.md) | [60.7](/filings/0001823608-26-000048.md) | [65.7](/filings/0001823608-25-000049.md) | [171](/filings/0001823608-25-000076.md) | [116](/filings/0001823608-25-000113.md) | [291](/filings/0001823608-26-000182.md) | [180](/filings/0001823608-26-000113.md) | [168](/filings/0001823608-26-000182.md) |
| Total assets | $m | [7,910](/filings/0001823608-23-000127.md) | [7,972](/filings/0001823608-25-000015.md) | [8,137](/filings/0001823608-24-000121.md) | [8,251](/filings/0001823608-24-000164.md) | [8,414](/filings/0001823608-24-000183.md) | [8,257](/filings/0001823608-26-000048.md) | [8,285](/filings/0001823608-25-000049.md) | [8,621](/filings/0001823608-25-000076.md) | [8,683](/filings/0001823608-25-000113.md) | [8,870](/filings/0001823608-26-000182.md) | [9,171](/filings/0001823608-26-000113.md) | [9,412](/filings/0001823608-26-000182.md) |
| Total liabilities | $m | [7,363](/filings/0001823608-23-000127.md) | [7,387](/filings/0001823608-25-000015.md) | [7,520](/filings/0001823608-24-000121.md) | [7,605](/filings/0001823608-24-000164.md) | [7,715](/filings/0001823608-24-000183.md) | [7,549](/filings/0001823608-26-000048.md) | [7,549](/filings/0001823608-25-000049.md) | [7,867](/filings/0001823608-25-000076.md) | [7,907](/filings/0001823608-25-000113.md) | [8,075](/filings/0001823608-26-000182.md) | [8,363](/filings/0001823608-26-000113.md) | [8,577](/filings/0001823608-26-000182.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [546](/filings/0001823608-23-000127.md) | [585](/filings/0001823608-25-000015.md) | [617](/filings/0001823608-24-000121.md) | [646](/filings/0001823608-24-000164.md) | [698](/filings/0001823608-24-000183.md) | [708](/filings/0001823608-25-000015.md) | [736](/filings/0001823608-26-000182.md) | [754](/filings/0001823608-26-000182.md) | [776](/filings/0001823608-25-000113.md) | [794](/filings/0001823608-26-000182.md) | [808](/filings/0001823608-26-000182.md) | [835](/filings/0001823608-26-000182.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [39.8 d](/filings/0001823608-24-000183.md) | [15.3 d](/filings/0001823608-26-000048.md) | [31.3](/filings/0001823608-25-000049.md) | [28.0 d](/filings/0001823608-25-000076.md) | [35.8 d](/filings/0001823608-25-000113.md) | [29.0 d](/filings/0001823608-26-000048.md) | [34.2](/filings/0001823608-26-000113.md) | [24.9 d](/filings/0001823608-26-000182.md) | [39.5 d](/filings/0001823608-25-000113.md) | [37.1 d](/filings/0001823608-26-000048.md) | [56.8](/filings/0001823608-26-000113.md) | [30.5 d](/filings/0001823608-26-000182.md) |
| Capital expenditure | $m | [0.4 d](/filings/0001823608-24-000183.md) | [0.3 d](/filings/0001823608-26-000048.md) | [0.2](/filings/0001823608-25-000049.md) | [0.2 d](/filings/0001823608-25-000076.md) | [0.6 d](/filings/0001823608-25-000113.md) | [0.7 d](/filings/0001823608-26-000048.md) | [1.8](/filings/0001823608-26-000113.md) | [(0.7) d](/filings/0001823608-26-000182.md) | [1.2 d](/filings/0001823608-25-000113.md) | [(0.9) d](/filings/0001823608-26-000048.md) | [6.1](/filings/0001823608-26-000113.md) | [10.9 d](/filings/0001823608-26-000182.md) |
| Dividends paid | $m | [3.1 d](/filings/0001823608-24-000183.md) | [3.1 d](/filings/0001823608-26-000048.md) | [3.1](/filings/0001823608-25-000049.md) | [3.7 d](/filings/0001823608-25-000076.md) | [3.7 d](/filings/0001823608-25-000113.md) | [3.7 d](/filings/0001823608-26-000048.md) | [4.3](/filings/0001823608-26-000113.md) | [4.5 d](/filings/0001823608-26-000182.md) | [4.2 d](/filings/0001823608-25-000113.md) | [4.2 d](/filings/0001823608-26-000048.md) | [5.3](/filings/0001823608-26-000113.md) | [5.1 d](/filings/0001823608-26-000182.md) |
| Share repurchases | $m | [2.6 d](/filings/0001823608-24-000183.md) | [1.1 d](/filings/0001823608-26-000048.md) | [0.3](/filings/0001823608-25-000049.md) | [0.0 d](/filings/0001823608-25-000076.md) | [0.0 d](/filings/0001823608-25-000113.md) | [0.8 d](/filings/0001823608-26-000048.md) | [3.5](/filings/0001823608-26-000113.md) | [9.7 d](/filings/0001823608-26-000182.md) | [10.4 d](/filings/0001823608-25-000113.md) | [8.7 d](/filings/0001823608-26-000048.md) | [2.8](/filings/0001823608-26-000113.md) | [0.0 d](/filings/0001823608-26-000182.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [31.0](/filings/0001823608-23-000127.md) | [30.9](/filings/0001823608-24-000121.md) | [30.8](/filings/0001823608-24-000164.md) | [30.6](/filings/0001823608-24-000183.md) | [30.7](/filings/0001823608-25-000049.md) | [30.8](/filings/0001823608-25-000076.md) | [30.9](/filings/0001823608-25-000113.md) | [30.9](/filings/0001823608-26-000113.md) | [30.8](/filings/0001823608-26-000182.md) | [30.4](/filings/0001823608-25-000113.md) | [30.2](/filings/0001823608-26-000113.md) | [30.2](/filings/0001823608-26-000182.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 29,900,147 at 2026-08-03, from the cover of the [10-Q filed 2026-08-04](/filings/0001823608-26-000182.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.